METTL3 and acute myeloid leukemia: Our most effective PROTAC, AF151, forms a stable complex between the E3 ligase von Hippel–Lindau (VHL) and the target-of-interest METTL3, demonstrating efficient METTL3 degradation (DC50 = 430 nM) in the AML cell line MOLM-13.